CN107118273B - 一种全人源抗补体因子h的抗体 - Google Patents
一种全人源抗补体因子h的抗体 Download PDFInfo
- Publication number
- CN107118273B CN107118273B CN201710340213.2A CN201710340213A CN107118273B CN 107118273 B CN107118273 B CN 107118273B CN 201710340213 A CN201710340213 A CN 201710340213A CN 107118273 B CN107118273 B CN 107118273B
- Authority
- CN
- China
- Prior art keywords
- cancer
- carcinoma
- antibody
- monoclonal antibody
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/626—Diabody or triabody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710340213.2A CN107118273B (zh) | 2017-05-15 | 2017-05-15 | 一种全人源抗补体因子h的抗体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710340213.2A CN107118273B (zh) | 2017-05-15 | 2017-05-15 | 一种全人源抗补体因子h的抗体 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107118273A CN107118273A (zh) | 2017-09-01 |
CN107118273B true CN107118273B (zh) | 2020-02-18 |
Family
ID=59727194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710340213.2A Active CN107118273B (zh) | 2017-05-15 | 2017-05-15 | 一种全人源抗补体因子h的抗体 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107118273B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102131898B1 (ko) * | 2017-10-31 | 2020-07-08 | 주식회사 노벨티노빌리티 | Scf 및 갈렉틴-1을 표적으로 하는 이중표적항체 및 그 용도 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102649975A (zh) * | 2011-02-23 | 2012-08-29 | 张康 | 补体因子h基因型、载脂蛋白上氧化磷酸胆碱和血浆补体因子h定量测定试剂盒及测定方法 |
CN102707068A (zh) * | 2012-05-31 | 2012-10-03 | 北京大学 | 补体h因子用作甲基苯丙胺成瘾患者的基因表达产物中的应用 |
CN106519030A (zh) * | 2016-12-22 | 2017-03-22 | 广州泰诺迪生物科技有限公司 | 补体因子h抑制剂及与之相关的用途 |
CN106519031A (zh) * | 2016-12-26 | 2017-03-22 | 广州泰诺迪生物科技有限公司 | 一种与旁路途径相关的cfh抗体 |
-
2017
- 2017-05-15 CN CN201710340213.2A patent/CN107118273B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102649975A (zh) * | 2011-02-23 | 2012-08-29 | 张康 | 补体因子h基因型、载脂蛋白上氧化磷酸胆碱和血浆补体因子h定量测定试剂盒及测定方法 |
CN102707068A (zh) * | 2012-05-31 | 2012-10-03 | 北京大学 | 补体h因子用作甲基苯丙胺成瘾患者的基因表达产物中的应用 |
CN106519030A (zh) * | 2016-12-22 | 2017-03-22 | 广州泰诺迪生物科技有限公司 | 补体因子h抑制剂及与之相关的用途 |
CN106519031A (zh) * | 2016-12-26 | 2017-03-22 | 广州泰诺迪生物科技有限公司 | 一种与旁路途径相关的cfh抗体 |
Also Published As
Publication number | Publication date |
---|---|
CN107118273A (zh) | 2017-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI796328B (zh) | B7-h3抗體、其抗原結合片段及其醫藥用途 | |
TWI845767B (zh) | 抗人Claudin18.2抗體及其應用 | |
US11472882B2 (en) | Anti-B7-H4 antibody, antigen-binding fragment thereof and pharmaceutical use thereof | |
TWI673287B (zh) | 抗b7-h3抗體、其抗原結合片段及其醫藥用途 | |
CN110577597A (zh) | 一种阻断CD47和SIRPα相互作用的抗体 | |
TWI840399B (zh) | 結合人il-4r的抗體、其抗原結合片段及其醫藥用途 | |
US11639388B2 (en) | CD3 antigen binding fragment and application thereof | |
US20220089709A1 (en) | Protein binding to fibronectin b domain | |
CN112243443B (zh) | 抗trop-2抗体、其抗原结合片段及其医药用途 | |
CN111744013A (zh) | 抗tigit抗体联合pd-1抑制剂治疗疾病的方法和药物组合 | |
US20230071422A1 (en) | ANTI-CD3 and ANTI-CD123 Bispecific Antibody and Use Thereof | |
WO2023125888A1 (zh) | 一种gprc5d抗体及其应用 | |
WO2024160076A1 (zh) | 针对人il-36r和/或人il-1r3的多种抗体及其用途 | |
CN114591434B (zh) | 抗Siglec15抗体及其制备方法和用途 | |
WO2019109947A1 (zh) | 抗人il6单克隆抗体及其制备方法和用途 | |
CN113227148B (zh) | 抗gpc3抗体、其抗原结合片段及其医药用途 | |
WO2021213245A1 (zh) | 抗体或其抗原结合片段、其制备方法及医药用途 | |
CN107118273B (zh) | 一种全人源抗补体因子h的抗体 | |
CA3152860A1 (en) | Anti-tfpi monoclonal antibodies | |
WO2021209066A1 (zh) | 特异性抗原结合分子,其制备方法及医药用途 | |
CN105001331B (zh) | 一种vegf单克隆抗体及其应用 | |
WO2022078424A1 (zh) | 抗trop-2抗体、其抗原结合片段或其突变体、及其医药用途 | |
TW202340240A (zh) | 多特異性抗體及其藥物用途 | |
CN116082504A (zh) | 靶向人lilrb2的纳米抗体及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 510300 unit 207, second floor, office area, No. 1, helix 4th Road, International Biological Island, Guangzhou, Guangdong Patentee after: GUANGZHOU TAINUODI BIOTECHNOLOGY Co.,Ltd. Patentee after: Zhuhai Tainuo Maibo Pharmaceutical Co.,Ltd. Patentee after: Jinan University Address before: 510300 unit 207, second floor, office area, No. 1, helix 4th Road, International Biological Island, Guangzhou, Guangdong Patentee before: GUANGZHOU TAINUODI BIOTECHNOLOGY Co.,Ltd. Patentee before: ZHUHAI TRINOMAB BIOTECHNOLOGY Co.,Ltd. Patentee before: Jinan University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230821 Address after: 519090 room 110, first floor, plant 6, No. 6366, Zhuhai Avenue, Jinwan District, Zhuhai City, Guangdong Province Patentee after: Zhuhai Tainuo Maibo Pharmaceutical Co.,Ltd. Patentee after: Jinan University Address before: 510300 unit 207, second floor, office area, No. 1, helix 4th Road, International Biological Island, Guangzhou, Guangdong Patentee before: GUANGZHOU TAINUODI BIOTECHNOLOGY Co.,Ltd. Patentee before: Zhuhai Tainuo Maibo Pharmaceutical Co.,Ltd. Patentee before: Jinan University |